tradingkey.logo

BRIEF-Apogee Therapeutics Announces Positive Interim Phase 1 Results From The APG990 Healthy Volunteer Trial

ReutersMar 3, 2025 11:10 AM

- Apogee Therapeutics APGE.O:

  • APOGEE THERAPEUTICS ANNOUNCES POSITIVE INTERIM PHASE 1 RESULTS FROM THE APG990 HEALTHY VOLUNTEER TRIAL, UNLOCKING POTENTIAL MAINTENANCE DOSING EVERY THREE AND SIX MONTHS FOR APG279 (APG777 + APG990)

  • APOGEE THERAPEUTICS INC - APG990 WELL TOLERATED UP TO 1,200MG DOSES

  • APOGEE THERAPEUTICS INC - MOST COMMON ADVERSE EVENT FOR APG990 WAS HEADACHE

  • APOGEE THERAPEUTICS INC - NO SEVERE ADVERSE EVENTS OR STUDY DISCONTINUATIONS FOR APG990

  • APOGEE THERAPEUTICS INC - TO INITIATE PHASE 1B TRIAL OF APG279 AGAINST DUPIXENT IN 2025

Source text: ID:nGNX4V8GW9

Further company coverage: APGE.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI